Pharmaceutical Suppositories Global Market Opportunities and Strategies to 2032

This report describes and explains the pharmaceutical suppositories market and covers 2017-2022, termed the historic period, and 2022-2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The global pharmaceutical suppositories market reached a value of nearly $1,510.0 million in 2022, having grown at a compound annual growth rate (CAGR) of 3.2% since 2017. The market is expected to grow from $1,510.0 million in 2022 to $1,970.0 million in 2027 at a rate of 5.5%. The market is then expected to grow at a CAGR of 6.7% from 2027 and reach $2,720.0 million in 2032.

Growth in the historic period resulted from increased healthcare expenditure, new regulatory approvals for marketing suppositories, government initiatives, the rise in prevalence of constipation and the increasing prevalence of diseases. Factors that negatively affected growth in the historic period were reluctance among patients and the coronavirus pandemic.

Going forward, aging population, an increase in prevalence of kidney damage or failure and an increase in prevalence of hemorrhoids will drive the growth. Factor that could hinder the growth of the pharmaceutical suppositories market in the future include the Russia- Ukraine war and the low-demand in underdeveloped countries.

The pharmaceutical suppositories market is segmented by type into rectal suppositories, vaginal suppositories, urethral suppositories and other types. The rectal suppositories market was the largest segment of the pharmaceutical suppositories market segmented by type, accounting for 67.2% of the total in 2022. Going forward, the vaginal suppositories segment is expected to be the fastest growing segment in the pharmaceutical suppositories market segmented by type, at a CAGR of 5.7% during 2022-2027.

The pharmaceutical suppositories market is segmented by base into fatty base, water miscible bases, and emulsifying bases. The emulsifying bases market was the largest segment of the pharmaceutical suppositories market segmented by base, accounting for 42.5% of the total in 2022. Going forward, the water miscible bases segment is expected to be the fastest growing segment in the pharmaceutical suppositories market segmented by base, at a CAGR of 5.7% during 2022-2027.

The pharmaceutical suppositories market is segmented by end-user into hospitals and clinics, nursing homes, home care, and other end users. The hospital and clinics market was the largest segment of the pharmaceutical suppositories market segmented by end-user, accounting for 52.9% of the total in 2022. Going forward, the hospital and clinics segment is expected to be the fastest growing segment in the pharmaceutical suppositories market segmented by end-user, at a CAGR of 5.50% during 2022-2027.

North America was the largest region in the pharmaceutical suppositories market, accounting for 39.1% of the total in 2022. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the pharmaceutical suppositories market will be Asia Pacific and Western Europe where growth will be at CAGRs of 6.2% and 5.6% respectively. These will be followed by North America and Eastern Europe where the markets are expected to grow at CAGRs of 5.3% and 5.2% respectively.

The global pharmaceutical suppositories market is concentrated, with a small number of large players in the market. The top ten competitors in the market made up 57.13% of the total market in 2021. This is due to the existence of a number of local players in the market serving customers in particular geographies. Bayer AG was the largest competitor with a 23.22% share of the market, followed by Pfizer Inc with 12.00%, Novartis International Ag with 7.50%, Sanofi S.A. with 5.65%, Intas Pharmaceuticals Ltd with 2.89%, Unither Pharmaceuticals with 1.61%, Cosette Pharmaceuticals, Inc with 1.45%, Aenova Holding GmbH with 1.25%, Delpharm with 1.01% and Bliss GVS Pharma Ltd with 0.54%.

The top opportunities in the pharmaceutical suppositories market segmented by type will arise in the rectal suppositories segment, which will gain $304.2 million of global annual sales by 2027. The top opportunities in the pharmaceutical suppositories market segmented by base will arise in the emulsifying bases segment, which will gain $194.5 million of global annual sales by 2027. The top opportunities in the pharmaceutical suppositories market segmented by end-user will arise in the hospital and clinics segment, which will gain $245.5 million of global annual sales by 2027. The pharmaceutical suppositories market size will gain the most in the USA at $154.3 million.

Market-trend-based strategies for the pharmaceutical suppositories market include focus on strategic partnerships, technological advancements, product innovation and focus on patient convenience and adherence.

To take advantage of the opportunities, the publisher recommends the pharmaceutical suppositories companies to focus on technological advancements, focus on product innovations, focus on patient convenience and adherence, expand in emerging markets, continue to focus on developed markets, focus on strategic partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to target fast-growing end-users and target the elderly population.